The growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer), new research shows. Inhibition of this receptor could be a new and effective way of treating patients.
The growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer), new research shows. Inhibition of this receptor could be a new and effective way of treating patients.